Cargando…

Predicting Alzheimer Disease From Mild Cognitive Impairment With a Deep Belief Network Based on 18F-FDG-PET Images

OBJECTIVE: Accurate diagnosis of early Alzheimer disease (AD) plays a critical role in preventing the progression of memory impairment. We aimed to develop a new deep belief network (DBN) framework using 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) metabolic imaging to identify pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Ting, Jiang, Jiehui, Lu, Jiaying, Wang, Min, Zuo, Chuantao, Yu, Zhihua, Yan, Zhuangzhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764042/ https://www.ncbi.nlm.nih.gov/pubmed/31552787 http://dx.doi.org/10.1177/1536012119877285

Ejemplares similares

Radiomics: a novel feature extraction method for brain neuron degeneration disease using (18)F-FDG PET imaging and its implementation for Alzheimer’s disease and mild cognitive impairment
por: Li, Yupeng, et al.
Publicado: (2019)

Based on Tau PET Radiomics Analysis for the Classification of Alzheimer’s Disease and Mild Cognitive Impairment
por: Jiao, Fangyang, et al.
Publicado: (2023)

A Novel Metabolic Connectome Method to Predict Progression to Mild Cognitive Impairment
por: Wang, Min, et al.
Publicado: (2020)

Dual-Model Radiomic Biomarkers Predict Development of Mild Cognitive Impairment Progression to Alzheimer’s Disease
por: Zhou, Hucheng, et al.
Publicado: (2019)

Study of the Influence of Age in (18)F-FDG PET Images Using a Data-Driven Approach and Its Evaluation in Alzheimer's Disease
por: Jiang, Jiehui, et al.
Publicado: (2018)

Individual brain metabolic connectome indicator based on Kullback-Leibler Divergence Similarity Estimation predicts progression from mild cognitive impairment to Alzheimer’s dementia
por: Wang, Min, et al.
Publicado: (2020)

Deep-Learning Radiomics for Discrimination Conversion of Alzheimer's Disease in Patients With Mild Cognitive Impairment: A Study Based on (18)F-FDG PET Imaging
por: Zhou, Ping, et al.
Publicado: (2021)

Combining PET with MRI to improve predictions of progression from mild cognitive impairment to Alzheimer’s disease: an exploratory radiomic analysis study
por: Yang, Fan, et al.
Publicado: (2022)

Arterial spin labeling versus (18)F-FDG-PET to identify mild cognitive impairment
por: Dolui, Sudipto, et al.
Publicado: (2019)

A novel individual-level morphological brain networks constructing method and its evaluation in PET and MR images
por: Jiang, Jiehui, et al.
Publicado: (2018)

Use of Overlapping Group LASSO Sparse Deep Belief Network to Discriminate Parkinson's Disease and Normal Control
por: Shen, Ting, et al.
Publicado: (2019)

(18)F-FDG PET for Prediction of Conversion to Alzheimer’s Disease Dementia in People with Mild Cognitive Impairment: An Updated Systematic Review of Test Accuracy
por: Smailagic, Nadja, et al.
Publicado: (2018)

The metabolic brain network in patients with Parkinson's disease based on (18)F-FDG PET imaging: evaluation of neuronal injury and regeneration
por: Ge, Jingjie, et al.
Publicado: (2014)

A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer’s disease, and mild cognitive impairment using brain 18F-FDG PET
por: Etminani, Kobra, et al.
Publicado: (2021)

(18)F-FDG-PET in Mouse Models of Alzheimer's Disease
por: Bouter, Caroline, et al.
Publicado: (2019)

Functional neuroimaging using F-18 FDG PET/CT in amnestic mild cognitive impairment: A preliminary study
por: Tripathi, Madhavi, et al.
Publicado: (2013)

Development of a Machine Learning Model to Discriminate Mild Cognitive Impairment Subjects from Normal Controls in Community Screening
por: Jiang, Juanjuan, et al.
Publicado: (2022)

Associations of [(18)F]-APN-1607 Tau PET Binding in the Brain of Alzheimer’s Disease Patients With Cognition and Glucose Metabolism
por: Lu, Jiaying, et al.
Publicado: (2020)

Mild Cognitive Impairment with a High Risk of Progression to Alzheimer’s Disease Dementia (MCI-HR-AD): Effect of Souvenaid(®) Treatment on Cognition and (18)F-FDG PET Scans
por: Manzano Palomo, Maria Sagrario, et al.
Publicado: (2019)

Precuneus and Cingulate Cortex Atrophy and Hypometabolism in Patients with Alzheimer's Disease and Mild Cognitive Impairment: MRI and (18)F-FDG PET Quantitative Analysis Using FreeSurfer
por: Bailly, Matthieu, et al.
Publicado: (2015)

Longer-Term Investigation of the Value of (18)F-FDG-PET and Magnetic Resonance Imaging for Predicting the Conversion of Mild Cognitive Impairment to Alzheimer’s Disease: A Multicenter Study
por: Inui, Yoshitaka, et al.
Publicado: (2017)

Analysis of the posterior cingulate cortex with [18F]FDG-PET and Naa/mI in mild cognitive impairment and Alzheimer's disease: Correlations and differences between the two methods
por: Coutinho, Artur M.N., et al.
Publicado: (2015)

Differential Diagnosis of Alzheimer Disease vs. Mild Cognitive Impairment Based on Left Temporal Lateral Lobe Hypomethabolism on (18)F-FDG PET/CT and Automated Classifiers
por: Nuvoli, Susanna, et al.
Publicado: (2022)

A Case Report of Early-Onset Alzheimer’s Disease Using (18)F-FDG PET and (18)F-FBB PET
por: Yoo, Jang, et al.
Publicado: (2023)

Parametric Estimation of Reference Signal Intensity for Semi-Quantification of Tau Deposition: A Flortaucipir and [(18)F]-APN-1607 Study
por: Zhang, Huiwei, et al.
Publicado: (2021)

In Vivo Tau Burden Is Associated with Abnormal Brain Functional Connectivity in Alzheimer’s Disease: A (18)F-Florzolotau Study
por: Ju, Zizhao, et al.
Publicado: (2022)

[(18)F]THK5351 PET Imaging in Patients with Mild Cognitive Impairment
por: Jeong, Hye Jin, et al.
Publicado: (2020)

Deep learning-based amyloid PET positivity classification model in the Alzheimer’s disease continuum by using 2-[(18)F]FDG PET
por: Kim, Suhong, et al.
Publicado: (2021)

Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer’s disease
por: Li, Yi, et al.
Publicado: (2008)

A deep learning approach for (18)F-FDG PET attenuation correction
por: Liu, Fang, et al.
Publicado: (2018)

PET probes beyond (18)F-FDG
por: Jiang, Lei, et al.
Publicado: (2014)

Diagnosis of Alzheimer’s Disease with [18F]PET in Mild and Asymptomatic Stages
por: Drzezga, Alexander
Publicado: (2009)

Measurement Repeatability of (18)F-FDG PET/CT Versus (18)F-FDG PET/MRI in Solid Tumors of the Pelvis
por: Fraum, Tyler J., et al.
Publicado: (2019)

Evaluation of 10-minute post-injection (11)C-PiB PET and its correlation with (18)F-FDG PET in older adults who are cognitively healthy, mildly impaired, or with probable Alzheimer’s disease
por: Carneiro, Camila de Godoi, et al.
Publicado: (2022)

Metabolic signature of hyposmia after mild COVID-19: An [18]F-FDG-pet study
por: Pardini, Matteo, et al.
Publicado: (2021)

Evaluation of the early-phase [(18)F]AV45 PET as an optimal surrogate of [(18)F]FDG PET in ageing and Alzheimer’s clinical syndrome
por: Vanhoutte, Matthieu, et al.
Publicado: (2021)

Distinct cerebral (18)F-FDG PET metabolic patterns in anti-N-methyl-D-aspartate receptor encephalitis patients with different trigger factors
por: Ge, Jingjie, et al.
Publicado: (2021)

The Efficacy of 18F-FDG PET/CT and Superparamagnetic Nanoferric Oxide MRI in the Diagnosis of Lung Cancer and the Value of 18F-FDG PET/CT in the Prediction of Lymph Node Metastasis
por: Yao, Lan, et al.
Publicado: (2021)

18F-FDG PET/MRI and 18F-FDG PET/CT for the Management of Gynecological Malignancies: A Comprehensive Review of the Literature
por: Allahqoli, Leila, et al.
Publicado: (2023)

Spectrum of the Breast Lesions With Increased 18F-FDG Uptake on PET/CT
por: Dong, Aisheng, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_i1b4g02slta1t4735fns3acj3e